Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 783-793

  Coto Segura, P ^a   Eiris Salvado, N ^a   Gonzalez Lara L ^a   Queiro Silva, R ^a   Martinez Camblor, P ^b   Maldonado Seral, C ^a   Garcia Garcia B ^a   Palacios Garcia L ^a   Gomez Bernal, S ^a   Santos Juanes, J ^a   Coto, E ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COCHRANE LIBRARY; DISEASE ASSOCIATION; EMBASE; HIGH RISK PATIENT; HUMAN; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUBLICATION; REVIEW; SYSTEMATIC REVIEW;

ARTHRITIS, PSORIATIC; DIABETES MELLITUS, TYPE 2; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PSORIASIS; PUBLICATION BIAS; RISK FACTORS;

EID: 84885585915     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12473     Document Type: Review

References (61)

1. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Gladman DD,. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2008. J Rheumatol 2010; 37: 446-7.
3. Henseler T, Christophers E,. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6.
4. Neimann AL, Shin DB, Wang X, et al,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-35.
5. Wild S, Roglic G, Green A, et al,. Global prevalence of diabetes. Diabetes Care 2004; 27: 1047-53.
6. Brownstein MH,. Psoriasis and diabetes mellitus. Arch Dermatol 1966; 93: 654-5.
7. Cheng J, Kuai D, Zhang L, et al,. Psoriasis increased the risk of diabetes: a meta-analysis. Arch Dermatol Res 2012; 304: 119-25.
8. Armstrong AW, Harskamp CT, Armstrong EJ,. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol 2013; 149: 84-91.
9. Stang A,. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
10. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
11. The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen: The Nordic Cochrane Centre, 2011.
12. Rosa DJ, Machado RF, Matias FA, et al,. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis. J Eur Acad Dermatol Venereol 2012; 26: 348-53.
13. Altobelli E, Petrocelli R, Maccarone M, et al,. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol 2009; 19: 252-6.
14. Lindegård B,. Diseases associated with psoriasis in a general population of 159 200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
15. Reeds JR, Fusaro RM, Fisher I,. Psoriasis vulgaris: I. A clinical survey of the association with diabetes mellitus. Arch Dermatol 1964; 89: 205-8.
16. Augustin M, Reich K, Glaeske G, et al,. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-51.
17. Qureshi AA, Choi HK, Setty AR, Curhan GC,. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009; 145: 379-82.
18. Prodanovich S, Kirsner RS, Kravetz JD, et al,. Association of psoriasis with coronary artery, cerebrovascular and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3.
19. Driessen RJ, Boezeman JB, Van De Kerkhof PC, De Jong EM,. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. J Dermatolog Treat 2009; 20: 42-7.
20. Gerdes S, Zahl VA, Knopf H, et al,. Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. Br J Dermatol 2008; 159: 1116-23.
21. Sommer DM, Jenisch S, Suchan M, et al,. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-8.
22. Warnecke C, Manousaridis I, Herr R, et al,. Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study. Eur J Dermatol 2011; 21: 761-70.
23. Chen YJ, Wu CY, Shen JL, et al,. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008; 144: 1571-5.
24. Wu Y, Mills D, Bala M,. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 2008; 7: 373-7.
25. Raychaudhuri SK, Chatterjee S, Nguyen C, et al,. Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis. Metab Syndr Relat Disord 2010; 8: 331-4.
26. Khraishi M, MacDonald D, Rampakakis E, et al,. Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 2011; 30: 877-85.
27. Zisman D, Eder L, Elias M, et al,. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int 2012; 32: 595-600.
28. Alexander E, Pinto J, Pal GS, et al,. Disease concomitance in psoriasis: a clinical study of 61 cases. Indian J Dermatol Venereol Leprol 2001; 67: 66-8.
29. Ghiasi M, Nouri M, Abbasi A, et al,. Psoriasis and increased prevalence of hypertension and diabetes mellitus. Indian J Dermatol 2011; 56: 533-6.
30. Huerta C, Rivero E, Rodríguez LA,. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65.
31. Shapiro J, Cohen AD, David M, et al,. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-34.
32. Gisondi P, Tessari G, Conti A, et al,. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
33. Naldi L, Chatenoud L, Belloni A, et al,. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology 2008; 216: 125-30.
34. Kimball AB, Robinson D Jr, Wu Y, et al,. Cardiovascular disease and risk factors among psoriasis patients in two U.S. healthcare databases, 2001-2002. Dermatology 2008; 217: 27-37.
35. Cohen AD, Dreiher J, Shapiro Y, et al,. Psoriasis and diabetes: a population-based cross-sectional study. J Eur Acad Dermatol Venereol 2008; 22: 585-9.
36. Brauchli YB, Jick SS, Meier CR,. Psoriasis and the risk of incident diabetes mellitus: a population-based study. Br J Dermatol 2008; 159: 1331-7.
37. Kaye JA, Li L, Jick SS,. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895-902.
38. Xiao J, Chen LH, Tu YT, et al,. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-15.
39. Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M,. Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 2010; 37: 146-55.
40. Schmitt J, Ford DE,. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2010; 24: 885-92.
41. Vena GA, Altomare G, Ayala F, et al,. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 2010; 20: 593-8.
42. Li W, Han J, Hu FB, et al,. Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. J Invest Dermatol 2012; 132: 291-8.
43. Shapiro J, Cohen AD, Weitzman D, et al,. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis. J Am Acad Dermatol 2012; 66: 252-8.
44. Armesto S, Santos-Juanes J, Galache-Osuna C, et al,. Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population. Australas J Dermatol 2012; 53: 128-30.
45. Han C, Robinson DW Jr, Hackett MV, et al,. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167-72.
46. Tam LS, Tomlinson B, Chu TT,. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology (Oxford) 2008; 47: 718-23.
47. Tobin AM, Veale DJ, Fitzgerald O, et al,. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol 2010; 37: 1386-94.
48. Cohen AD, Gilutz H, Henkin Y, et al,. Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007; 87: 506-9.
49. Cohen AD, Sherf M, Vidavsky L, et al,. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-5.
50. Nisa N, Qazi MA,. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol 2010; 76: 662-5.
51. Takahashi H, Takahashi I, Honma M, et al,. Prevalence of metabolic syndrome in Japanese psoriasis patients. J Dermatol Sci 2010; 57: 132-46.
52. Tseng HW, Lin HS, Lam HC,. Co-morbidities in psoriasis: a hospital-based case-control study. J Eur Acad Dermatol Venereol 2012; doi: 10.1111/jdv.12028 [Epub ahead of print].
53. Xu XC, Feng AP,. Characteristics of patients with psoriasis and type 2 diabetes in a central China case-control study. Eur J Dermatol 2012; 22: 396-7.
54. Solomon DH, Love TJ, Canning C, Schneeweiss S,. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010; 69: 2114-17.
55. Mehta NN, Yu Y, Pinnelas R, et al,. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124: 775.e1-6.
56. Langan SM, Seminara NM, Shin DB, et al,. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-62.
57. Azfar RS, Seminara NM, Shin DB, et al,. Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol 2012; 148: 995-1000.
58. Blettner M, Sauerbrei W, Schlehofer B, et al,. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 1999; 28: 1-9.
59. Mather HM, Keen H,. The Southall diabetes survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985; 291: 1081-4.
60. Mok CC, Ko GT, Ho LY, et al,. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken) 2011; 63: 195-202.
61. Taylor R,. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008; 51: 1781-9.